These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34536990)

  • 1. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
    Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
    Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
    Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
    BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK.
    Marciniak A; Glover K; Sharma R
    BMJ Open; 2017 Jan; 7(1):e012240. PubMed ID: 28131996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients.
    Abe Y; Akamatsu K; Ito K; Matsumura Y; Shimeno K; Naruko T; Takahashi Y; Shibata T; Yoshiyama M
    Circ J; 2018 Apr; 82(5):1451-1458. PubMed ID: 29553091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Zhang H; El-Am EA; Thaden JJ; Pislaru SV; Scott CG; Krittanawong C; Chahal AA; Breen TJ; Eleid MF; Melduni RM; Greason KL; McCully RB; Enriquez-Sarano M; Oh JK; Pellikka PA; Nkomo VT
    Heart; 2020 Feb; 106(4):280-286. PubMed ID: 31439661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.
    Samad Z; Sivak JA; Phelan M; Schulte PJ; Patel U; Velazquez EJ
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29021274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry.
    Sani MU; Davison BA; Cotter G; Mayosi BM; Edwards C; Ogah OS; Damasceno A; Ojji DB; Dzudie A; Mondo C; Kouam CK; Suliman A; Yonga G; Ba SA; Maru F; Alemayehu B; Sliwa K
    Cardiovasc J Afr; 2018; 29(3):139-145. PubMed ID: 30067272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease.
    Takahashi Y; Izumi C; Miyake M; Imanaka M; Kuroda M; Nishimura S; Yoshikawa Y; Amano M; Imamura S; Onishi N; Tamaki Y; Enomoto S; Tamura T; Kondo H; Kaitani K; Nakagawa Y
    Int J Cardiol; 2017 Sep; 243():251-257. PubMed ID: 28536002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black Adults.
    Matsushita K; Gao Y; Rubin J; Kirtane AJ; Kodali S; Selvin E; Alonso A; Leon MB; Solomon SD; Coresh J; Fox ER; Shah AM
    JAMA Netw Open; 2022 May; 5(5):e2211946. PubMed ID: 35552723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis.
    Zilberszac R; Gleiss A; Binder T; Laufer G; Grimm M; Gabriel H; Maurer G; Rosenhek R
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):985-992. PubMed ID: 29506023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of valvular regurgitation in catheter ablation outcomes of patients with long-standing persistent atrial fibrillation.
    Zhao L; Jiang W; Zhou L; Gu J; Wang Y; Liu Y; Zhang X; Wu S; Liu X
    Europace; 2014 Jun; 16(6):848-54. PubMed ID: 24163415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    Prapan N; Ratanasit N; Karaketklang K
    BMC Cardiovasc Disord; 2020 Oct; 20(1):433. PubMed ID: 33023481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
    Dreyfus J; Komar M; Attias D; De Bonis M; Ruschitzka F; Popescu BA; Laroche C; Tribouilloy C; Bogachev Prokophiev A; Mizariene V; Bax JJ; Maggioni AP; Messika-Zeitoun D; Vahanian A; Iung B;
    Eur J Heart Fail; 2024 Apr; 26(4):994-1003. PubMed ID: 38374610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Arora S; Vemulapalli S; Stebbins A; Ramm CJ; Kosinski AS; Sorajja P; Piccini JP; Cavender MA; Vavalle JP
    JACC Cardiovasc Interv; 2019 Mar; 12(6):569-578. PubMed ID: 30898255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regurgitant valvular disease prevalence and progression found on echocardiogram in military aviators.
    Davis SM; Davenport ED; Haynes JT; Alvarado RL
    Aviat Space Environ Med; 2014 Oct; 85(10):1013-8. PubMed ID: 25245901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction.
    Schupp T; Abel N; Schmidberger M; Höpfner MK; Schmitt A; Reinhardt M; Forner J; Lau F; Akin M; Rusnak J; Akin I; Behnes M
    Eur J Heart Fail; 2024 Aug; 26(8):1832-1846. PubMed ID: 38896059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis.
    Banerjee A; Allan V; Denaxas S; Shah A; Kotecha D; Lambiase PD; Joseph J; Lund LH; Hemingway H
    Europace; 2019 Dec; 21(12):1776-1784. PubMed ID: 31408153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.